SPONSORED CONTENT Since this article was published, HRSA released new guidance on a proposed pilot rebate model. This pilot would […]
SPONSORED CONTENT The regulatory landscape for the 340B drug pricing program is evolving rapidly. As scrutiny from the Health Resources […]
SPONSORED CONTENT AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just […]
SPONSORED CONTENT Introduction: Navigating Political Headwinds As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD […]
SPONSORED CONTENT Let’s be honest. 340B compliance is demanding. It takes time, coordination, and precision. After more than a decade […]
SPONSORED CONTENT Location: Gaylord National Resort & Convention Center, Fort Washington, MD 340B stakeholders headed to the 340B Coalition Summer […]
SPONSORED CONTENT The 340B program is facing a period of unprecedented change. With the Inflation Reduction Act (IRA) and Medicare’s […]
SPONSORED CONTENT Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit […]
SPONSORED CONTENT In today’s 340B environment, every claim counts. With increased oversight, tighter margins, and growing manufacturer restrictions, covered entities […]
SPONSORED CONTENT The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), […]